Anti-angiogenesis Treatment with PTK/ZK in Ovarian Cancer: A Phase IB, Open Label, Safety and Pharmacokinetics (PK) Study of Escalating Doses of PTK787/ZK 222584 (PTK/ZK) in Combination With Paclitaxel and Carboplatin in Patients (pts) With Stage IC to IV Epithelial Ovarian Cancer

Authors
Publication date
20 March 2006
Publisher
German Medical Science; Düsseldorf, Köln

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    German Medical Science

    redirect
    oaioai:oai-gms.dimdi.de:GM06dkk55...
    Last time updated on 09/07/2019